By Michael Komorn
Pregnancy and Medical Marijuana
Expectant mothers are searching for answers about the safety profile of Medical Marijuana. Unfortunately the scientific community has dropped the ball and kicked it off the cliff on this issue. The lack of scientific research is due to marijuana’s illegality. Further, there exist huge biases within the published research. Mostly the research confounds marijuana use with tobacco and/or alcohol, two known causes of fetus and child harm. Separating out marijuana effects from the self-reported research on mothers who also smoke tobacco and drink alcohol is impossible. Likewise no pregnant women are signing up for research studies due to the illegality of marijuana and CPS removing children from mothers for testing positive for marijuana use.
Many organizations quote from other organizations, who quote from other studies and reviews. The Minnesota Department of Health OFFICE OF MEDICAL CANNABIS quotes from the American College of Obstetricians and Gynecologists Committee report:
In the American College of Obstetricians and Gynecologists official committee opinion, interim update Oct 2017, the committee found:
Uninformed opinion, with zero evidence and lots of fear, uncertainty and doubt (FUD) are used to scare mothers away from a nontoxic plant. These uninformed unscientific opinions are being used by lawmakers to craft laws continuing the cycle of FUD and the illegality of marijuana. “Oh we don’t know what marijuana does, so let’s treat it like heroin” and “if anyone questions our opinion of marijuana, we’ll call them dirty lazy pothead stoner hippies” or “puppets of the marijuana industry”.
But we do know what marijuana does. One cannot live in a bubble and ignore reality and the world around us. Women smoke and eat marijuana while pregnant.
Cannabis use during pregnancy in France in 2010
Trends in Self-reported and Biochemically Tested Marijuana Use Among Pregnant Females in California From 2009-2016
Much of the opinions on marijuana are tainted by a small number of poorly designed studies on marijuana. For example, the National Institute of Health gives grants to researchers through NIDA, the National Institute of Drug Abuse, to study marijuana. NIDA’s focus is on drug abuse, so 90% of its grants are for studies on marijuana abuse, not marijuana benefits. When you ignore half of your research, you ignore science. Many of these studies are completed in order to get future grants from NIDA; research is often conducted from the conclusion backwards in order to show some kind of harm from marijuana use. This, in of itself, does not bias research.
The bias is introduced when researchers are rushed and forced to publish results, even if the studies were deficient. For example, every website and newspaper ran with the story about marijuana using children lose IQ points. Not many reported on the follow-up study that could not replicate the first study. When eliminating co-founders, the new study found no drop in IQ points. Further, research on twin siblings showed that the drop in IQ was due to parenting, binge drinking or other societal influences, not marijuana.
Try reading that last sentence again. In a world of science, evidence, reasoning and logic, a doctor makes a statement that decades of use of marijuana might make you lose intellectual function, based on conjecture.
NIDA also continues to perpetuate the myth that Marijuana is a “gateway drug”.
These findings are consistent with the idea of marijuana as a "gateway drug." However, the majority of people who use marijuana do not go on to use other, "harder" substances.
NIDA, NIH, FDA, DEA, including other federal, state, and local government organizations and private companies continue to perpetuate these and other lies in order to keep marijuana illegal. ASA has filed complaints against the DEA multiple times to get it to remove incorrect statements about marijuana off of the DEA’s website.
A cyclical pattern emerges from the current and past situation surrounding marijuana.
1. Stymied scientific research, due to illegality of marijuana and government funding biases
2. Using stymied scientific research as a reason to ignore reality.
3. Repeating the biased scientific research, long after it was shown to be deficient.
4. Using the deficient biased research in “meta-reviews”. Thus taking bad science as a base to create more bad science just by doing an analysis of the bad science conclusions.
5. Even after a research study has been fully proven to be deficient and conflicting with better research, continue to hold it up as if it is still valid in some way.
6. Publish opinions as if they were facts, without any data to back up any claims.
Continue reading for more conflicting studies and more calls for research.
Marijuana: Prenatal and Postnatal Exposure in the Human
Marijuana use in pregnancy and lactation: a review of the evidence
Marijuana and Pregnancy
The Association of Marijuana Use with Outcome of Pregnancy
Prenatal Tobacco, Marijuana, Stimulant, and Opiate Exposure: Outcomes and Practice Implications
Many of these studies contradict themselves. Some report differences in birth weight, some show no differences. Read the studies yourself!
House bill 5422 will force MMFLA provisioning centers to give patients and caregivers an unscientific pamphlet, as described by the legislature.
HB 5222 looks like it will pass. All this fear and doubt of a non-toxic 5,000+ year old medication used by millions of humans in every country in the world.
By Michael Komorn
Medical marijuana used to treat autism-related disorders
PALM BEACH COUNTY, Fla. — Abigail Dar’s son, Yuval, is 24-years-old, and she says he is severely autistic.
Mollie Ryckman Barrett’s youngest daughter, Sumer, is 13-years-old and has Asperger Syndrome. This is the story of two moms looking for answers to help their children.
"Medication helps, at times. Sumer, who is doing well in seventh grade, takes two of them," Barrett said. “One helps her focus with her brain and one relaxes her brain a little bit.”
Always, though, there is the nagging worry. “How safe really is the medication we are giving our children today?” asked Barrett.
Dar gave her autistic son higher and higher doses of pharmaceutical prescription medications for years in a bid to control his anxiety and aggressiveness.
Dar complained, “They just give medication hoping it will give an answer, which it doesn’t, and I get my kid crazier and crazier.”
Amid that frustration, Dar had an alternative within reach.
“Israel is much more liberal regarding medical cannabis,” Dar said.
Dar spoke from her home outside Tel Aviv, Israel, where she is at the forefront of medical marijuana research. “I gave him (Yuval) his first dose and it was a miracle,” she remembered.
The dose she talked about was a strain of medical cannabis she and her son’s psychiatrist settled on after trial and error. Yuval became calmer, less anxious, more attentive.
“It’s a game changer,” Abigail said, “it gave us quality of life.”
Barrett said she wants the same opportunity for her daughter, but their home in West Palm Beach, Florida is far removed from the access, and attitudes, available in Israel.
“We should have a right to decide in our home what is in the best interest of our children, what is the safest alternative option for them,” Barrett said.
She said she hopes to someday use cannabis derived oils for Sumer, but her child’s doctor does not agree with the idea. “He just says,” Barrett recalled, “that he doesn’t feel it’s a safe option and she seems OK on her medicine and there really are no side effects.”
The American Academy of Pediatrics does not support medical marijuana use for autism-related disorders. One big issue, experts say, is the fact that there are many strains of cannabinoids in marijuana.
Dr. Norina Ocampo is a South Florida pediatrician. “The other issue is they think probably all these compounds work synergistically with each other to help, so how do you pick which one will be the right compound,” she said.
Dar is working with Israeli doctors, pushing for much more extensive research on that prime question. “Today we have over 300 kids having access to medical cannabis,” she said.
Medical marijuana used to treat autism-related disorders
9:56 PM, Feb 5, 2018
2:03 PM, Feb 6, 2018
By Michael Komorn
The Michigan State Police are hiring!
They are looking for a “Narcotics Intelligence Analyst” to “Focus on providing assistance to the Medical Marihuana Investigation Section (MMIS) with marihuana investigations related to the Michigan Medical Marihuana Act, Medical Marihuana Facilities Licensing Act, and Marihuana Tracking Act.”
There is also a position available for a combination Marihuana and Tobacco Tax Investigation Section within the State Police.
One of the duties of this MSP Trooper Tax Enforcer position is to coordinate with Federal enforcement agencies and prosecutors.
Maintain a working relationship with courts, prosecutors and other enforcement agencies at federal, state and local levels. Initiate positive interaction with court personnel, federal, county and state prosecutors. Assist federal, state and local law enforcement agencies on complaints related to theft of cigarettes and all tobacco
smuggling. It is interesting that the Michigan State Police are now getting on board with Medical Marihuana in Michigan. Official statements and policy by the MSP in the past have all been against the MMMA and MMFLA at multiple points.
When the MMMA became law, police officers were not trained how to handle medical marijuana situations.
Ken Stecker from the Prosecuting Attorneys Association of Michigan did a reefer madness type propaganda power point presentation around the state explaining the MMMA to various law enforcement agents and organizations.
Ken Stecker included propaganda such as this in his “updated presentation” on Michigan’s Medical Marihuana Program. Why was a person, not affiliated in any way with the State of Michigan, going around doing talks with local, county and state police officers about a medical law?
What is this Medical Marijuana Investigation Section?
The House Legislative Analysis explains what HB 4209 (Public Act 281 of 2016) aka the MMFLA does for law enforcement:
The Department of State Police (MSP) would provide 34.0 FTEs for criminal enforcement activities related to medical marihuana at an annual cost of $6.0 million. This assumption is based on the personnel employed by the MSP to provide criminal enforcement activities for the Michigan Casino Gaming Board (MGCB). The Department of Attorney General (AG) would provide 4.0 FTEs for legal and prosecutorial support related to medical marihuana at an annual cost of $500,000.
After being against the MMMA, the MMFLA, patients, caregivers, and everything possibly to do with medical marijuana, the Michigan State Police now have to regulate and enforce it.
Compliance Checks? Marijuana Tracking ACT ?
The Seed to Sale , or Marijuana Tracking ACT is a law in Michigan to track and report all sales, transfers, processes, manufacturing and cultivation within the MMFLA.
It allows law enforcement agencies to verify and enforce regulations in the MMFLA, including the tracking of patient and caregiver purchases within the retail state-licensed MMFLA dispensaries.
Ultimately, the police have inserted themselves between you and your doctor. The police asked for these regulations during the MMFLA law drafting committees and senate and house hearings on these bills. The police want to look at the MMFLA registry and if you have bought too much marijuana from the system within some random arbitrary window of time, they are going to want to investigate you. Just for the medical use of marijuana as granted by the State of Michigan.
It is sad that the police are enforcing patient’s medication with jail time.
By Michael Komorn
Oral cannabis extracts as a promising treatment for the core symptoms of autism spectrum disorder: Preliminary experience in Chilean patients
G. Kuester , K. Vergara , A. Ahumada , A.M. Gazmuri DOI: http://dx.doi.org/10.1016/j.jns.2017.08.2623 Background: Preclinical studies and several anecdotal case reports suggest a dysfunctional endocannabinoid system implicated in Autism Spectrum Disorder (ASD).
Objective: To report our preliminary findings in patients with ASD treated with oral cannabis extracts.
Patients and Methods/Material and Methods: We retrospectively reviewed all consecutive patients seen between June 2016-March 2017, with ASD diagnosis according to DSM-V, treated with sublingual whole plant cannabis extracts for at least three months. We reviewed demographic/clinical data, neuroimaging/EEG studies, vision/audition/genetic/metabolic tests, and parental/school/neuropsychological reports. Type of cannabis strain, CBD:THC ratio, daily dose of CBD/THC/CBN, and adverse events were documented. Clinical changes were estimated using Clinical Global Impression of Improvement (CGI-I) and Autism Parenting Stress Index (APSI). Informed consent was obtained.
Results: 20 children and one adult patients were selected. Mean age: 9 years, 10 months (range: 26 mo-22 yo), 15 males. Mean follow-up: 7,6 mo (range: 3-12). 66,7% of patients had significant improvement according to CGI-I and APSI. Most cases improved at least one of the core symptoms of ASD, including social communication, language, or repetitive behaviors. Additionally, sensory difficulties, food acceptance, feeding and sleep disorders, and/or seizures were improved in most cases. 71,5% of patients received balanced CBD:THC extracts; 19,0% high-CBD; and 9,5% high-THC extracts. Oral cannabis extracts were well tolerated. Two patients had more agitation and one had more irritability, effects that were solved by changing the strain.
Conclusion: In this small series of ASD patients, oral cannabis extracts were dramatically more effective than conventional medicines. Large randomized controlled trials are needed to establish efficacy and safety of medicinal cannabis in ASD.
USA -- Using marijuana does not cause changes in brain volume, a new study suggests.Public health experts have cited concerns that using marijuana could be associated with structural changes in the brain.
However, a new trial comparing the brains of marijuana users and non-users to their siblings reveals that marijuana use likely does not cause changes in brain volume.